Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 8

1.

Yeast two hybrid analyses reveal novel binary interactions between human cytomegalovirus-encoded virion proteins.

To A, Bai Y, Shen A, Gong H, Umamoto S, Lu S, Liu F.

PLoS One. 2011 Apr 1;6(4):e17796. doi: 10.1371/journal.pone.0017796.

2.

Salmonella-mediated delivery of RNase P-based ribozymes for inhibition of viral gene expression and replication in human cells.

Bai Y, Li H, Vu GP, Gong H, Umamoto S, Zhou T, Lu S, Liu F.

Proc Natl Acad Sci U S A. 2010 Apr 20;107(16):7269-74. doi: 10.1073/pnas.0912813107. Epub 2010 Apr 1.

3.

Infection of human cytomegalovirus in cultured human gingival tissue.

Hai R, Chu A, Li H, Umamoto S, Rider P, Liu F.

Virol J. 2006 Oct 5;3:84.

4.
5.

The cytomegalovirus m155 gene product subverts natural killer cell antiviral protection by disruption of H60-NKG2D interactions.

Lodoen MB, Abenes G, Umamoto S, Houchins JP, Liu F, Lanier LL.

J Exp Med. 2004 Oct 18;200(8):1075-81. Epub 2004 Oct 11.

6.

RNase P ribozyme inhibits cytomegalovirus replication by blocking the expression of viral capsid proteins.

Kim K, Trang P, Umamoto S, Hai R, Liu F.

Nucleic Acids Res. 2004 Jun 25;32(11):3427-34. Print 2004.

8.

Engineered RNase P ribozymes are efficient in cleaving a human cytomegalovirus mRNA in vitro and are effective in inhibiting viral gene expression and growth in human cells.

Zou H, Lee J, Umamoto S, Kilani AF, Kim J, Trang P, Zhou T, Liu F.

J Biol Chem. 2003 Sep 26;278(39):37265-74. Epub 2003 Jul 15.

Supplemental Content

Loading ...
Support Center